Patents by Inventor Vishva Dixit

Vishva Dixit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11066463
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: July 20, 2021
    Assignee: Genentech, Inc.
    Inventors: Vishva Dixit, Robert F. Kelley, Marissa L. Matsumoto
  • Publication number: 20210017260
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Application
    Filed: June 29, 2020
    Publication date: January 21, 2021
    Applicant: Genentech Inc.
    Inventors: Robert F. Kelley, Vishva Dixit, Marissa L. Matsumoto
  • Patent number: 10738106
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: August 11, 2020
    Assignee: Genentech, Inc.
    Inventors: Robert F. Kelley, Vishva Dixit, Marissa L. Matsumoto
  • Publication number: 20190169278
    Abstract: The invention provides antibodies having greater avidity for a mixed-topology polyubiquitin than a single-topology polyubiquitin and multispecific anti-polyubiquitin antibodies, and methods of using the same.
    Type: Application
    Filed: December 6, 2018
    Publication date: June 6, 2019
    Applicant: Genentech, Inc.
    Inventors: Vishva Dixit, Marissa Matsumoto, Erick Castellanos
  • Publication number: 20190100578
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Application
    Filed: September 14, 2018
    Publication date: April 4, 2019
    Applicant: Genentech, Inc.
    Inventors: Vishva Dixit, Robert F. Kelley, Marissa L. Matsumoto
  • Patent number: 10100105
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: October 16, 2018
    Assignee: Genentech, Inc.
    Inventors: Vishva Dixit, Robert F. Kelley, Marissa L. Matsumoto
  • Publication number: 20170240620
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Application
    Filed: December 16, 2016
    Publication date: August 24, 2017
    Applicant: Genentech, Inc.
    Inventors: Vishva Dixit, Robert F. Kelley, Marissa L. Matsumoto
  • Patent number: 9556262
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: January 31, 2017
    Assignee: Genentech, Inc.
    Inventors: Vishva Dixit, Robert F. Kelley, Marissa L. Matsumoto
  • Publication number: 20160304591
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Application
    Filed: March 16, 2016
    Publication date: October 20, 2016
    Inventors: Robert F. Kelley, Vishva Dixit, Marissa L. Matsumoto
  • Patent number: 9321844
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Grant
    Filed: August 6, 2012
    Date of Patent: April 26, 2016
    Assignee: Genentech, Inc.
    Inventors: Robert F. Kelley, Vishva Dixit, Marissa L. Matsumoto
  • Publication number: 20150307602
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Application
    Filed: February 20, 2015
    Publication date: October 29, 2015
    Inventors: Vishva Dixit, Robert F. Kelley, Marissa L. Matsumoto
  • Patent number: 8992919
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Grant
    Filed: April 14, 2011
    Date of Patent: March 31, 2015
    Assignee: Genentech, Inc.
    Inventors: Vishva Dixit, Robert F. Kelley, Marissa L. Matsumoto
  • Publication number: 20130058955
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Application
    Filed: August 6, 2012
    Publication date: March 7, 2013
    Applicant: GENENTECH, INC.
    Inventors: Robert F. Kelley, Vishva Dixit, Marissa L. Matsumoto
  • Publication number: 20110256133
    Abstract: The invention provides anti-polyubiquitin antibodies and methods of using the same.
    Type: Application
    Filed: April 14, 2011
    Publication date: October 20, 2011
    Applicant: GENENTECH, INC.
    Inventors: VISHVA DIXIT, ROBERT F. KELLEY, MARISSA L. MATSUMOTO
  • Publication number: 20110045474
    Abstract: The invention provides diagnostic, prognostic, and therapeutic uses for detecting COP1 overexpression in a variety of cancers. The methods and uses can further include detecting p53 expression. The invention also provides reagents and kits for use in screening for test compounds that interfere with COP1 and p53 binding.
    Type: Application
    Filed: June 29, 2010
    Publication date: February 24, 2011
    Inventors: David Dornan, Dorothy French, Vishva Dixit
  • Patent number: 7785815
    Abstract: The invention provides diagnostic, prognostic, and therapeutic uses for detecting COP1 overexpression in a variety of cancers. The methods and uses can further include detecting p53 expression. The invention also provides reagents and kits for use in screening for test compounds that interfere with COP1 and p53 binding.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: August 31, 2010
    Assignee: Genentech, Inc.
    Inventors: David Dornan, Dorothy French, Vishva Dixit
  • Publication number: 20100087624
    Abstract: The invention provided improved methods of making and producing recombinant proteins in in vitro cultures of host cells using apoptosis inhibitors. The use of one or more apoptosis inhibitors in the methods can reduce apoptosis in the cell cultures and markedly improve yield of the desired recombinant proteins.
    Type: Application
    Filed: November 30, 2009
    Publication date: April 8, 2010
    Inventors: Vishva Dixit, Robert W. Hamilton, Jana van de Van de Goor
  • Publication number: 20080057066
    Abstract: Anti-RELT monoclonal antibodies, and methods for using the antibodies, are provided. Methods of using RELT polypeptides and nucleic acids in modulating immune cell development and in modulating cytokine production are also provided.
    Type: Application
    Filed: February 12, 2007
    Publication date: March 6, 2008
    Inventors: Vishva Dixit, Nobuhiko Kayagaki, Yan Wu
  • Publication number: 20080009458
    Abstract: The invention provides diagnostic, prognostic, and therapeutic uses for detecting COP1 overexpression in a variety of cancers. The methods and uses can further include detecting p53 expression. The invention also provides reagents and kits for use in screening for test compounds that interfere with COP1 and p53 binding.
    Type: Application
    Filed: April 10, 2007
    Publication date: January 10, 2008
    Inventors: David Dornan, Dorothy French, Vishva Dixit
  • Publication number: 20070004009
    Abstract: The invention provided improved methods of making and producing recombinant proteins in in vitro cultures of host cells using apoptosis inhibitors. The use of one or more apoptosis inhibitors in the methods can reduce apoptosis in the cell cultures and markedly improve yield of the desired recombinant proteins.
    Type: Application
    Filed: June 15, 2006
    Publication date: January 4, 2007
    Inventors: Vishva Dixit, Robert Hamilton, Jana van de Goor